These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 7085860)
1. Intravenous immune globulin: its use and potential. Proceedings of a workshop. San Francisco, California, November 23, 1981. J Clin Immunol; 1982 Apr; 2(2 Suppl):1S-48S. PubMed ID: 7085860 [No Abstract] [Full Text] [Related]
2. Innovative uses of intravenous immunoglobulins in clinical hematology. Symposium. December 5, 1986, San Francisco, California. Proceedings. Am J Med; 1987 Oct; 83(4A):1-56. PubMed ID: 3118702 [No Abstract] [Full Text] [Related]
5. Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteers. Hopkins RJ; Kramer WG; Blackwelder WC; Ashtekar M; Hague L; Winker-La Roche SD; Berezuk G; Smith D; Leese PT Clin Infect Dis; 2004 Sep; 39(6):759-66. PubMed ID: 15472804 [TBL] [Abstract][Full Text] [Related]
6. Subcutaneous immune globulin (SCIG). Med Lett Drugs Ther; 2007 Apr; 49(1258):31-2. PubMed ID: 17415283 [No Abstract] [Full Text] [Related]
7. Infant botulism: a 30-year experience spanning the introduction of botulism immune globulin intravenous in the intensive care unit at Childrens Hospital Los Angeles. Underwood K; Rubin S; Deakers T; Newth C Pediatrics; 2007 Dec; 120(6):e1380-5. PubMed ID: 18055655 [TBL] [Abstract][Full Text] [Related]
8. [Response to combined therapy with plasmapheresis and high doses of immunoglobulin in Lambert-Eaton syndrome]. Díez-Tejedor E; Tejada J; Ramos MJ; Frank A; Cruz-Martínez A; Vivancos F; Barreiro P Neurologia; 1994 Feb; 9(2):76-7. PubMed ID: 8204254 [No Abstract] [Full Text] [Related]
9. Intravenous immune globulin use in Canada. Hanna K; Poulin-Costello M; Preston M; Maresky N Can J Clin Pharmacol; 2003; 10(1):11-6. PubMed ID: 12687032 [TBL] [Abstract][Full Text] [Related]
10. [Workshop on subcutaneous immunoglobulins: why and how? Vivaglobin. SNFMI, December 7, 2006]. Lambert M Rev Med Interne; 2007 Jun; 28(6):436-40. PubMed ID: 17459535 [No Abstract] [Full Text] [Related]
11. Madras pattern of motor neuron disease: improvement of symptoms with intravenous immunoglobulin. Fan D; Fu Y; Sun A; Kang D Natl Med J India; 2004; 17(3):141-2. PubMed ID: 15253401 [TBL] [Abstract][Full Text] [Related]
12. Immune globulin prophylaxis for viral hepatitis: to give or not to give. Sampliner RE Md State Med J; 1980 Apr; 29(4):43-5. PubMed ID: 7382564 [No Abstract] [Full Text] [Related]
13. New insights into the management of myocardial ischemia. San Francisco, California, November 3-4, 1989. Proceedings of a symposium. Am Heart J; 1990 Sep; 120(3):719-72. PubMed ID: 2389717 [No Abstract] [Full Text] [Related]
14. Intravenous immune globulin (Gamimune). Med Lett Drugs Ther; 1982 Sep; 24(617):81-2. PubMed ID: 7110057 [No Abstract] [Full Text] [Related]
16. [Intravenous immunoglobulins in the treatment of neurologic diseases]. Illa I; Serrano C Neurologia; 1996; 11(6):220-8. PubMed ID: 8768678 [No Abstract] [Full Text] [Related]
18. Managing the shortage of intravenous immune globulin. Decker EL; Gouveia WA Am J Health Syst Pharm; 1998 Oct; 55(20):2090, 2093. PubMed ID: 9988567 [No Abstract] [Full Text] [Related]
19. Immune globulin use at a multihospital medical center. Gajewski LK; Bailey EM; Brown PD; Chandrasekar PH Am J Hosp Pharm; 1994 Mar; 51(6):801-5. PubMed ID: 8010320 [TBL] [Abstract][Full Text] [Related]
20. Comment on the article 'Intravenous immunoglobulins: pharmacological aspects and therapeutic use' by A. Hässig. Rohm D; Stephan W Vox Sang; 1987; 52(1-2):158. PubMed ID: 3604163 [No Abstract] [Full Text] [Related] [Next] [New Search]